| Today, Sat, Jul 11, 2009 | | • | [$$] Shippers Sink Tokyo, In 8th Loss
at The Wall Street Journal Online (Sat 12:04am)
| | Fri, Jul 10, 2009 | | • | Portola inks potential $470M Merck deal
at bizjournals.com (Fri 9:05am)
| | Thu, Jul 9, 2009 | | • | Swine Flu Update: Vaccine for Kids, Tamiflu Resistance
at The Wall Street Journal Online (Thu, Jul 9)
| | • | Software Giants Rush to Cash In on Carbon-Trading
at CNBC (Thu, Jul 9)
| | • | Rapamycin: It's Not Just for Longevity in Mice
at The Wall Street Journal Online (Thu, Jul 9)
| | • | Homeland Security Braces for Possible H1N1 Outbreak
at CNBC (Thu, Jul 9)
| | • | No Bone to Pick With Amgen
at Barron's Online (Thu, Jul 9)
| | • | Riddle Of The Methuselah Mice
at Forbes.com (Thu, Jul 9)
| | • | [$$] Merck Acquires Rights to Anticoagulant
at The Wall Street Journal Online (Thu, Jul 9)
| | • | Analyst Picks and Pans: Amgen, RF Micro, Chattem
at BusinessWeek (Thu, Jul 9)
| | • | Amgen May Have a Winner on Its Hands
at Seeking Alpha (Thu, Jul 9)
| | • | Amgen's D-mab Debate
at Seeking Alpha (Thu, Jul 9)
| | Wed, Jul 8, 2009 | | • | EU warns of antitrust probes into drug makers
AP (Wed, Jul 8)
| | • | Results on Amgen bone drug helps stock
at bizjournals.com (Wed, Jul 8)
| | • | Amgen Closes In on a Home Run
at Motley Fool (Wed, Jul 8)
| | • | Amgen's Denosumab Strengthens Bones, Stocks
Indie Research (Wed, Jul 8)
| | • | Aryx Keeps Biotech Investors Humble
at TheStreet.com (Wed, Jul 8)
| | • | Amgen shares climb 15% on bone-drug trial
at MarketWatch (Wed, Jul 8)
| | • | Amgen's Denosumab an Improvement
Zacks.com (Wed, Jul 8)
| | • | Amgen shares rise on positive bone-drug study
AP (Wed, Jul 8)
|
Add NVS News to My Yahoo!:
 
| |
|
0.45% Nasdaq 
0.20%
Headlines
